Get started
Author

K. K. Karnakova

ORCID: 0000-0002-4010-1231
Observed ORCID: 0000-0002-4010-1231
OpenAlex ID: A5092082798
Phase I pharmacokinetic study of etmaben, a malonic acid derivative
2024 · P. K. Karnakova, K. K. Karnakova, et al. · Drug development & registration · 2
Development and Validation of an HPLC-MS/MS Method for Quantification of Apixaban in Human Plasma
2024 · U. D. Filonova, P. K. Karnakova, et al. · Drug development & registration · 2
PDF
Application of in vitro studies to predict the pharmacokinetics of rivaroxaban tablets
2024 · A. V. Suvorova, P. A. Losenkova, et al. · Drug development & registration · 1
PDF
Study of pharmacokinetic parameters and safety of the drug Duonica® in comparison with the original combination of doxylamine and pyridoxine under fed conditions
2024 · I. E. Shohin, S. M. Noskov, et al. · Pharmacokinetics and Pharmacodynamics · 1
Phase I Pharmacokinetics Study of Drug Areplivir® Zinc (INN: Favipiravir + Zinc Gluconate) (LLC "PROMOMED RUS", Russia)
2024 · T. N. Komarov, N. S. Bagaeva, et al. · Drug development & registration · 1
PDF
Reciprocal Impact of Molnupiravir and Favipiravir Monocomponents of the Combination Drug on Each Other's Pharmacokinetics in a Phase I Clinical Trial
2024 · T. N. Komarov, K. K. Karnakova, et al. · Drug development & registration · 1
PDF
Phase I Pharmacokinetics Study of Drug for Infusion «Areplivir» (INN: Favipiravir) (LLC "PROMOMED RUS", Russia)
2023 · T. N. Komarov, N. S. Bagaeva, et al. · Drug development & registration · 1
PDF
Development and validation of a high-performance liquid chromatography with tandem mass spectrometry method for quantification of tofacitinib in human plasma
2024 · E. S. Vetrova, P. K. Karnakova, et al. · Drug development & registration
Phase I Pharmacokinetics Study of Oral Administration of Esperavir® (INN: Molnupiravir) (LLC "PROMOMED RUS", Russia)
2024 · T. N. Komarov, N. S. Bagaeva, et al. · Drug development & registration
PDF
Works count: 9
Citation count: 9
H-index: 2
I10-index:
Year
Topic
Type